Pharma channel feed

Paxlovid didn’t short­en Covid symp­toms in vac­ci­nat­ed adults, full tri­al re­sults con­firm

Last year
FDA+
Coronavirus

Judge of­fers ear­ly win for Ar­bu­tus as Mod­er­na vac­cine patent spat heats up

Last year
Law

Sanofi ends al­most all state per­son­al in­jury law­suits over Zan­tac with undis­closed set­tle­ment

Last year
Law

Ex­perts ap­plaud Amy­lyx for keep­ing its promise to with­draw ALS drug Re­lyvrio af­ter tri­al fail­ure

Last year

Amy­lyx to vol­un­tar­i­ly with­draw ALS drug Re­lyvrio af­ter Phase 3 fail, will lay off around 70%

Last year
People

FDA ap­proves Basilea’s an­tibi­ot­ic for se­vere bac­te­r­i­al in­fec­tions

Last year
FDA+

WuXi builds out lob­by­ing bench amid leg­isla­tive ef­fort to black­list com­pa­ny

Last year
China
FDA+

Q&A: Gen­mab CEO on ink­ing the first ac­qui­si­tion in the com­pa­ny's 25-year his­to­ry

Last year
Deals

Har­ris Poll notes in­crease in phar­ma rep­u­ta­tion among Amer­i­cans who know about GLP-1 drugs

Last year
Marketing

Biden’s plan for hos­pi­tals to pay more for drugs in short­age is ‘mis­guid­ed,’ group says

Last year
Manufacturing

'We beat big phar­ma': Biden ap­plauds IRA, calls for ex­pan­sion of Medicare ne­go­ti­a­tions

Last year
FDA+

Ad­di­tion­al drug­mak­ers flag risks of work­ing with WuXi amid height­ened US scruti­ny

Last year
R&D
Manufacturing

Al­most all dos­es of Moun­jaro, Zep­bound in short sup­ply through Q2

Last year
FDA+

US re­sponds to drug­mak­er­s' IRA coun­terof­fers as Medicare price ne­go­ti­a­tions con­tin­ue

Last year

Ab­b­Vie com­mits to ‘mak­ing the big bets’ in new cor­po­rate cam­paign

Last year
Marketing

Fed­er­al court gives Te­va and Vi­a­tris an­oth­er chance to in­val­i­date J&J's last patent for In­ve­ga Susten­na

Last year
Law

Mar­ket­ingRx roundup: Pfiz­er switch­es up ad­ver­tis­ing du­ties; No­vo Nordisk’s Ozem­pic gets spoofed on SNL

Last year
Marketing

Phar­ma is bet­ting big on con­nect­ing po­ten­tial pa­tients to its med­ica­tions. It's just the be­gin­ning

Last year
Marketing

Acor­da files for bank­rupt­cy, agrees to sell MS drug and oth­er as­sets to Merz for $185M

Last year
Deals

Ipsen boards ADC train in $900M pact with Sutro

Last year
Deals

CBER's Marks points to stock­piles of H5N1 vac­cine as of­fi­cials mon­i­tor re­port­ed hu­man case

Last year
FDA+

EU­'s phar­ma leg­isla­tive re­forms 'will scare in­vest­ment away,' Astel­las ex­ec­u­tive says

Last year
Law

Gilead part­ners for ball­room danc­ing work­shop on sex­u­al health and HIV pre­ven­tion

Last year
Marketing

Eiger files for bank­rupt­cy and will wind down op­er­a­tions af­ter years of set­backs

Last year
People
First page Previous page 63646566676869 Next page Last page
A service from the Financial Times